NurA Is Endowed with Endo- and Exonuclease Activities that Are Modulated by HerA: New Insight into Their Role in DNA-End Processing

PLoS One. 2015 Nov 11;10(11):e0142345. doi: 10.1371/journal.pone.0142345. eCollection 2015.

Abstract

The nuclease NurA and the ATPase HerA are present in all known thermophilic archaea and cooperate with the highly conserved MRE11/RAD50 proteins to facilitate efficient DNA double-strand break end processing during homologous recombinational repair. However, contradictory results have been reported on the exact activities and mutual dependence of these two enzymes. To understand the functional relationship between these two enzymes we deeply characterized Sulfolobus solfataricus NurA and HerA proteins. We found that NurA is endowed with exo- and endonuclease activities on various DNA substrates, including linear (single-stranded and double stranded) as well as circular molecules (single stranded and supercoiled double-stranded). All these activities are not strictly dependent on the presence of HerA, require divalent ions (preferably Mn2+), and are inhibited by the presence of ATP. The endo- and exonculease activities have distinct requirements: whereas the exonuclease activity on linear DNA fragments is stimulated by HerA and depends on the catalytic D58 residue, the endonuclease activity on circular double-stranded DNA is HerA-independent and is not affected by the D58A mutation. On the basis of our results we propose a mechanism of action of NurA/HerA complex during DNA end processing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Archaeal Proteins / genetics*
  • Archaeal Proteins / metabolism
  • DNA
  • DNA Repair / physiology*
  • Endodeoxyribonucleases / genetics*
  • Endodeoxyribonucleases / metabolism
  • Exodeoxyribonucleases / genetics*
  • Exodeoxyribonucleases / metabolism
  • Models, Molecular
  • Sulfolobus solfataricus / genetics*
  • Sulfolobus solfataricus / metabolism

Substances

  • Archaeal Proteins
  • DNA
  • Endodeoxyribonucleases
  • Exodeoxyribonucleases

Grants and funding

This work was supported by MERIT Molecular Oncology -RBNE08YFN3.